BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35469840)

  • 1. KIT as a master regulator of the mast cell lineage.
    Tsai M; Valent P; Galli SJ
    J Allergy Clin Immunol; 2022 Jun; 149(6):1845-1854. PubMed ID: 35469840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others.
    Galli SJ; Tsai M; Wershil BK
    Am J Pathol; 1993 Apr; 142(4):965-74. PubMed ID: 7682764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.
    Kalesnikoff J; Rios EJ; Chen CC; Nakae S; Zabel BA; Butcher EC; Tsai M; Tam SY; Galli SJ
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2659-64. PubMed ID: 16533754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function.
    Wershil BK; Tsai M; Geissler EN; Zsebo KM; Galli SJ
    J Exp Med; 1992 Jan; 175(1):245-55. PubMed ID: 1370530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of Kit.
    Shimizu Y; Ashman LK; Du Z; Schwartz LB
    J Immunol; 1996 May; 156(9):3443-9. PubMed ID: 8617971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells.
    Simon C; Dondi E; Chaix A; de Sepulveda P; Kubiseski TJ; Varin-Blank N; Velazquez L
    Blood; 2008 Nov; 112(10):4039-47. PubMed ID: 18753636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group 2 innate lymphoid cells (ILC2) are regulated by stem cell factor during chronic asthmatic disease.
    Fonseca W; Rasky AJ; Ptaschinski C; Morris SH; Best SKK; Phillips M; Malinczak CA; Lukacs NW
    Mucosal Immunol; 2019 Mar; 12(2):445-456. PubMed ID: 30617299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling.
    Ho CCM; Chhabra A; Starkl P; Schnorr PJ; Wilmes S; Moraga I; Kwon HS; Gaudenzio N; Sibilano R; Wehrman TS; Gakovic M; Sockolosky JT; Tiffany MR; Ring AM; Piehler J; Weissman IL; Galli SJ; Shizuru JA; Garcia KC
    Cell; 2017 Mar; 168(6):1041-1052.e18. PubMed ID: 28283060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FES kinase promotes mast cell recruitment to mammary tumors via the stem cell factor/KIT receptor signaling axis.
    Kwok E; Everingham S; Zhang S; Greer PA; Allingham JS; Craig AW
    Mol Cancer Res; 2012 Jul; 10(7):881-91. PubMed ID: 22589410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical role for stem cell factor and c-kit in host protective immunity to an intestinal helminth.
    Donaldson LE; Schmitt E; Huntley JF; Newlands GF; Grencis RK
    Int Immunol; 1996 Apr; 8(4):559-67. PubMed ID: 8671643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of c-kit receptor tyrosine kinase in the development, survival and neoplastic transformation of mast cells.
    Tsujimura T
    Pathol Int; 1996 Dec; 46(12):933-8. PubMed ID: 9110344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biology of stem cell factor and its receptor C-kit.
    Ashman LK
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1037-51. PubMed ID: 10582338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
    Shivakrupa R; Bernstein A; Watring N; Linnekin D
    Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.
    Reber L; Da Silva CA; Frossard N
    Eur J Pharmacol; 2006 Mar; 533(1-3):327-40. PubMed ID: 16483568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells.
    Maurer M; Echtenacher B; Hültner L; Kollias G; Männel DN; Langley KE; Galli SJ
    J Exp Med; 1998 Dec; 188(12):2343-8. PubMed ID: 9858520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation and differentiation of spermatogonial stem cells in the w/wv mutant mouse testis.
    Ohta H; Tohda A; Nishimune Y
    Biol Reprod; 2003 Dec; 69(6):1815-21. PubMed ID: 12890724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIN3 is a negative regulator of mast cell responses to SCF.
    Janson C; Kasahara N; Prendergast GC; Colicelli J
    PLoS One; 2012; 7(11):e49615. PubMed ID: 23185384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell factor expression, mast cells and inflammation in asthma.
    Da Silva CA; Reber L; Frossard N
    Fundam Clin Pharmacol; 2006 Feb; 20(1):21-39. PubMed ID: 16448392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting kit activation: a potential therapeutic approach in the treatment of allergic inflammation.
    Jensen BM; Metcalfe DD; Gilfillan AM
    Inflamm Allergy Drug Targets; 2007 Mar; 6(1):57-62. PubMed ID: 17352689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
    Förster A; Grotha SP; Seeger JM; Rabenhorst A; Gehring M; Raap U; Létard S; Dubreuil P; Kashkar H; Walczak H; Roers A; Hartmann K
    Allergy; 2015 Jul; 70(7):764-74. PubMed ID: 25833810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.